Skip to main navigation
Skip to search
Skip to main content
Utrecht University Home
Help & FAQ
Home
Profiles
Research units
Research output
Activities
Press/Media
Prizes
Search by expertise, name or affiliation
Treatment of female sexual dysfunction: A personalized medicine approach
K. van Rooij
Pharmacology
Research output
:
Thesis
›
Doctoral thesis 1 (Research UU / Graduation UU)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Treatment of female sexual dysfunction: A personalized medicine approach'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Personalized Medicine
100%
Female Sexual Dysfunction
100%
Disorders of Arousal
100%
Female Sexual Arousal Disorder
100%
Sublingual Testosterone
87%
Sexual Stimuli
62%
Sexual Complaints
50%
Free Testosterone
37%
Polymorphism
25%
Sexual Behavior
25%
Plasma Parameters
25%
Pharmacokinetics
25%
5-HT1A Receptor Agonist
25%
Testosterone
25%
Testosterone Administration
25%
Inhibitory Mechanism
25%
Sex Hormone-binding Globulin
25%
Buspirone
25%
Sildenafil
25%
Causal Mechanisms
25%
Plasma Concentration
12%
Psychological Factors
12%
Genetic Factors
12%
Biological Factors
12%
Genetic Polymorphism
12%
Behavioral Effects
12%
On Demand
12%
Arousal
12%
DSM-5
12%
Statistical Manual of Mental Disorders
12%
Pharmacological Treatment
12%
High Inhibition
12%
Sexual Arousal
12%
Low Sexual Desire
12%
Personal Distress
12%
Gender-specific
12%
Pharmacodynamic Interactions
12%
Sexual Interest
12%
Sexual Dissatisfaction
12%
Sexual Cues
12%
PDE5 Inhibitors
12%
Combination Tablet
12%
Post-SSRI Sexual Dysfunction
12%
5th Edition
12%
Dose Factor
12%
SSRI Antidepressants
12%
Buspirone Hydrochloride
12%
Hormonal Levels
12%
On-demand Treatment
12%
Total Testosterone
12%
Point of View Analysis
12%
Distinct Subtypes
12%
Biologically Active Substances
12%
Medicine and Dentistry
Selective Serotonin Reuptake Inhibitor
100%
Personalized Medicine
100%
Buspirone
60%
Testosterone
60%
Pharmacokinetics
40%
DSM-5
40%
K-Complex
40%
Sex Hormone Binding Globulin
40%
5-HT1A Receptors
40%
Sildenafil
40%
Medicine
20%
Pharmacodynamics
20%
Heredity
20%
Phosphodiesterase V Inhibitor
20%
Psychological Aspect
20%
Behavioral Effect
20%
Genetic Polymorphism
20%
Biological Factor
20%
Pharmacological Treatment
20%
Neuroscience
Selective Serotonin Reuptake Inhibitor
100%
Testosterone
60%
Buspirone
60%
Blood Plasma
60%
Receptor Agonists
40%
5-HT1A Receptor
40%
Sex Hormone Binding Globulin
40%
Pharmacokinetics
40%
Sildenafil
40%
Individual Differences
20%
Behavioral Effect
20%
PDE5 Inhibitor
20%
Genetic Polymorphism
20%
Diagnostic and Statistical Manual of Mental Disorders
20%
Pharmacology, Toxicology and Pharmaceutical Science
Selective Serotonin Reuptake Inhibitor
100%
Buspirone
60%
Testosterone
60%
Receptor Agonist
40%
Sildenafil
40%
Sex Hormone Binding Globulin
40%
DSM-5
40%
Pharmacokinetics
40%
Pharmacodynamics
20%
Tablet
20%
Behavioral Effect
20%
Phosphodiesterase V Inhibitor
20%
Psychological Aspect
20%
Biological Factor
20%
Biochemistry, Genetics and Molecular Biology
K-Complex
100%
Selective Serotonin Reuptake Inhibitor
50%
Buspirone
30%
Testosterone
30%
Sex Hormone-Binding Globulin
20%
Blood Level
20%
Receptor Agonists
20%
DSM-5
20%
Pharmacokinetics
20%
5-HT1A Receptor
20%
Genetics
10%
Genetic Determinism
10%
Genetic Polymorphism
10%
Psychological Aspect
10%
Pharmacodynamics
10%
Maximum Plasma Concentration
10%
Psychology
Testosterone
100%
Individual Differences
33%
Psychological Factor
33%
Personal Distress
33%
Psychology
33%